英派药业-B(07630)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

07630 英派药业-B

已收盘 05-19 16:08:19

38.800

+0.640

+1.68%

最高39.680	最低36.980	成交量39.09万
今开37.440	昨收38.160	日振幅7.08%
总市值107.15亿	流通市值107.15亿	总股本2.76亿
成交额1,505万	换手率0.14%	流通股本2.76亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"07630","market":"HK","secType":"STK","nameCN":"英派药业-B","latestPrice":38.8,"timestamp":1779178099141,"preClose":38.16,"halted":0,"volume":390900,"delay":0,"changeRate":0.016771488469601692,"floatShares":276165130,"shares":276165130,"eps":-1.440772,"marketStatus":"已收盘","change":0.64,"latestTime":"05-19 16:08:19","open":37.44,"high":39.68,"low":36.98,"amount":15052112,"amplitude":0.070755,"askPrice":39.5,"askSize":200,"bidPrice":38.8,"bidSize":600,"shortable":0,"etf":0,"ttmEps":-1.186,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779240600000},"marketStatusCode":5,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":38.16,"openAndCloseTimeList":[[1779154200000,1779163200000],[1779166800000,1779177600000]],"volumeRatio":0.082063,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/07630","defaultTab":"news","newsList":[{"id":"2636835929","title":"港股异动 | 英派药业-B(07630)尾盘涨近4% 核心产品塞纳帕利去年12月已纳入医保","url":"https://stock-news.laohu8.com/highlight/detail?id=2636835929","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636835929?lang=zh_cn&edition=full","pubTime":"2026-05-19 15:49","pubTimestamp":1779176941,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英派药业-B尾盘涨近4%，截至发稿，涨3.93%，报39.66港元，成交额1382.25万港元。国投证券国际指出，英派药业为国内合成致死赛道的制药企业，已与Eikon、华东医药达成战略合作，核心产品塞纳帕利已纳入医保，短期可关注其医保放量和EMA上市申请审批进度，长期看其他管线临床数据读出及商业化进展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443384.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07630","BK4588","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145155707","title":"异动解读 | 英派药业-B盘中大涨6.95%，上市表现强劲、核心产品纳入医保及创新管线潜力受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=1145155707","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145155707?lang=zh_cn&edition=full","pubTime":"2026-05-15 09:41","pubTimestamp":1778809313,"startTime":"0","endTime":"0","summary":"英派药业-B今日盘中大涨6.95%，引起了市场的广泛关注。消息面上，公司于5月13日以每股20.10港元定价登陆港交所，香港公开发售获2282.4倍超额认购，一手中签率仅1.5%，首日收报41.86港元，较招股价涨108.26%，上市后市场情绪延续强势。此外，公司核心产品塞纳帕利已于2025年1月获批用于卵巢癌一线维持治疗，并于2025年12月纳入国家医保目录，自今年1月起正式执行医保价格，有望推动营收持续放量。公司在研管线IMP32为全球首个靶向CEACAM5的双载荷ADC，具备First-in-Class地位，展示了公司的研发实力和未来增长潜力，进一步增强了投资者信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635201905","title":"【新股IPO】英派药业(07630)首挂收报41.86港元 较招股价高108.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635201905","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635201905?lang=zh_cn&edition=full","pubTime":"2026-05-13 16:16","pubTimestamp":1778660200,"startTime":"0","endTime":"0","summary":"金吾财讯 | 英派药业(07630)首挂收报41.86港元，较招股价高108.26%，全日成交1513.5万股，成交额5.44亿港元，不计手续费，每手200股，账面赚4352港元。该股早盘开报35.5港元，较招股价高76.62%，全日最低33.1港元，最高见45.8港元。最新总市值115.6亿港元。","market":"fut","thumbnail":"https://static.szfiu.com/news/20220324/YjI0MWRiZGM3ZjA2MTU3MTE2NDgwOTA4MzEyNTY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/YjI0MWRiZGM3ZjA2MTU3MTE2NDgwOTA4MzEyNTY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1981283","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPCX","IPOS","07630","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198038909","title":"港股异动 | 英派药业-B首日高开高走，股价涨幅扩大至117%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198038909","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198038909?lang=zh_cn&edition=full","pubTime":"2026-05-13 12:00","pubTimestamp":1778644826,"startTime":"0","endTime":"0","summary":"5月13日，$英派药业-B$首日高开高走，截止发稿股价涨超117%。核心产品派舒宁已于2025年1月获得中国国家药品监督管理局批准上市，并于2025年12月纳入国家基本医保目录。此外，英派的IMP32是全球首个、且目前唯一靶向CEACAM5的TOP1i+ATRi双载荷ADC，具备明确的First-in-Class地位。随着塞纳帕利自 2026 年1月1日起正式执行国家医保目录价格，叠加公司在研管线持续推进、有望持续兑现更多里程碑收益，有望实现营收规模持续快速放量增长。","market":"hk","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8b649ba7014e19fc207e00040e470eb9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119412752","title":"异动解读 | 英派药业-B盘中大涨65.67%，首日挂牌获超2282倍认购热捧","url":"https://stock-news.laohu8.com/highlight/detail?id=1119412752","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119412752?lang=zh_cn&edition=full","pubTime":"2026-05-13 09:38","pubTimestamp":1778636290,"startTime":"0","endTime":"0","summary":"英派药业-B今日盘中大涨65.67%，引起了市场的广泛关注。消息面上，该公司今日正式在香港联交所主板挂牌上市。根据公布的配发结果，英派药业-B的香港公开发售部分获得了约2282.4倍的巨额超额认购，国际发售部分也获得约24.58倍超额认购。公开资料显示，英派药业是一家处于商业化阶段的生物技术公司，致力于在全球范围内开发基于合成致死机制的精准抗癌疗法。公司核心产品塞纳帕利已于2025年1月在中国获批用于卵巢癌一线维持治疗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8b649ba7014e19fc207e00040e470eb9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635422730","title":"新股首日 | 英派药业-B(07630)首挂上市 早盘高开76.62% 公司专注于合成致死领域的精准抗癌药物领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2635422730","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635422730?lang=zh_cn&edition=full","pubTime":"2026-05-13 09:26","pubTimestamp":1778635604,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英派药业-B首挂上市，公告显示，每股定价20.1港元，共发行4197.7万股股份，每手200股，所得款项净额约7.6亿港元。截至发稿，涨76.62%，报35.5港元，成交额2.07亿港元。公开资料显示，英派药业是一家处于商业化阶段的生物技术公司，致力于在全球范围内推进基于合成致死机制的精准抗癌疗法，打造创新疗法，以满足癌症患者未被满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195209254","title":"英派药业-B香港首秀：开盘价定为每股35.5港元，较发行价20.10港元大幅溢价","url":"https://stock-news.laohu8.com/highlight/detail?id=1195209254","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195209254?lang=zh_cn&edition=full","pubTime":"2026-05-13 09:21","pubTimestamp":1778635297,"startTime":"0","endTime":"0","summary":"英派药业-B（股票代码：07630）即将在香港交易所迎来其首日交易，市场瞩目的开盘价已定为每股35.5港元。这一价格显著高于其每股20.10港元的首次公开募股（IPO）发行价，预示着该生物科技公司获得了资本市场的热烈追捧。\n开盘价与发行价之间高达76.6%的溢价空间，直观地反映了投资者对英派药业-B发展前景的强烈信心。在生物医药板块持续受到关注的背景下，公司此次上市表现无疑成为市场焦点。强劲的认购需求和积极的定价，为公司在公开市场的亮相奠定了坚实的基础，也为后续交易日的走势提供了重要的初始动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8b649ba7014e19fc207e00040e470eb9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100453375","title":"港股开盘 | 恒指高开0.08%，科指低开0.3%！剂泰科技-P首挂涨超173%、英派药业-B首挂涨超76%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100453375","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100453375?lang=zh_cn&edition=full","pubTime":"2026-05-13 09:20","pubTimestamp":1778635230,"startTime":"0","endTime":"0","summary":"5月13日，港股开盘，恒指开涨0.08%，科指开跌0.3%。京东涨超3%，Q1营收同比小幅增长，调整后EBITDA远超预期，外卖业务亏损环比大幅收窄；泡泡玛特涨近4%，Q1收入预增75％至80％，欧美市场增长放缓，中国线上渠道预增150%；剂泰科技-P首挂涨超173%，公开发售阶段获6910.96倍认购，一手中签率0.14%；英派药业-B首挂涨超76%，公开发售阶段获2282.4倍认购，一手中签率1.5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"18a40ba5e41ea1a9f349b7fe41577e93","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03032","VXUS","03115","BK4588","02800","09115","07300","03423","07226","09088","03037","02837","03419","07666","82800","513600","07200","07552","07500","07630","03067","BK4585","09067","HSI","03417","83115","02833","03088","03033"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120887345","title":"新股定价 | 英派药业每股发售价20.1港元，公开发售超购2281.4倍、一手中签率1.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120887345","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120887345?lang=zh_cn&edition=full","pubTime":"2026-05-13 08:08","pubTimestamp":1778630893,"startTime":"0","endTime":"0","summary":" $英派药业-B(07630)$ (07630)今日挂牌，此前公布配发结果，公司全球发售4197.7万股H股，香港公开发售占10%，国际发售占90%。每股发售价20.1港元，全球发售净筹约7.6亿港元。每手200股H股，一手中签率1.5%。其中，香港公开发售获2282.4倍认购，国际发售获24.58倍认购。","market":"us","thumbnail":"https://community-static.tradeup.com/news/41fafb343260e3b8496a1cce4618abec","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/41fafb343260e3b8496a1cce4618abec"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3430ee0e05254278b5a3da84a7b77b4c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"新股定价 | 英派药业每股发售价20.1港元，公开发售超购2281.4倍、一手中签率1.5%","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107392450","title":"英派药业-B全球发售最终发售价定为每股H股20.10港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1107392450","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107392450?lang=zh_cn&edition=full","pubTime":"2026-05-12 23:09","pubTimestamp":1778598591,"startTime":"0","endTime":"0","summary":"根据最新公告，英派药业-B（股票代码：07630.HK）已确定其全球发售的最终发售价为每股H股20.10港元。此次定价标志着公司上市进程中的关键一步已完成。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634221026","title":"英派药业-B(07630.HK)香港公开发售获2282.4倍认购 5月13日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2634221026","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634221026?lang=zh_cn&edition=full","pubTime":"2026-05-12 22:17","pubTimestamp":1778595424,"startTime":"0","endTime":"0","summary":"格隆汇5月12日丨英派药业-B(07630.HK)公告，公司全球发售41,977,000股H股，每股H股20.10港元，所得款项净额7.6亿港元。香港公开发售股份数目占全球发售股份数目10%，获认购2,282.4倍；国际发售股份数目占全球发售股份90%，获认购倍24.58倍。\r\n\r\n　　假设全球发售于2026年5月13日(星期三)上午八时正或之前(香港时间)成为无条件，预期H股将于2026年5月13日(星期三)上午九时正(香港时间)开始在联交所买卖。H股将以200股H股为一手买卖单位进行交易，H股的股份代号为7630。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260512/32218965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["07630","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119222532","title":"英派药业-B香港IPO录得2282倍超购 5月13日登陆主板","url":"https://stock-news.laohu8.com/highlight/detail?id=1119222532","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119222532?lang=zh_cn&edition=full","pubTime":"2026-05-12 21:56","pubTimestamp":1778594171,"startTime":"0","endTime":"0","summary":"南京英派药业股份有限公司公布招股结果。公司本次全球发售共发行4,197.7万股H股，另设最多629.64万股超额配股权。最终发售价定为每股20.10港元，按此计算，预计募资总额约8.44亿元，扣除约0.84亿元发行费用后，募资净额约7.60亿元。公司H股将于2026年5月13日（星期三）在香港联交所主板挂牌交易，每手200股。公司共接获221,788份有效申请，合共认购95.8亿股，超购倍数高达2,282.4倍；本次香港公开发售最终配售4,197,800股H股，占全球发售股份的10%，未触发回补机制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8b649ba7014e19fc207e00040e470eb9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634649214","title":"英派药业明日上市：暗盘涨60% 公司市值89亿港元 腾讯是股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2634649214","media":"雷递网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634649214?lang=zh_cn&edition=full","pubTime":"2026-05-12 20:59","pubTimestamp":1778590749,"startTime":"0","endTime":"0","summary":"南京英派药业股份有限公司（简称：“英派药业”，股票代码：“07630”）将于明日港交所上市。","market":"sh","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260512/6391421634656021866631568.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260512/6391421634656021866631568.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n33638/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["LU1951186391.HKD","IE00B0169L03.USD","IE0008368742.USD","LU0634319403.HKD","LU0456846285.SGD","SG9999006514.SGD","LU2087589342.USD","IE00BGV7N243.SGD","LU2498475776.HKD","LU2097828805.USD","LU1880383440.USD","BK4504","LU1242518857.USD","LU0320764243.SGD","IE0001KFT4U8.USD","LU0210527791.USD","LU0509642566.USD","LU0611395673.USD","LU0164880469.USD","LU1568876335.HKD","SG9999014906.USD","LU2242644610.SGD","SG9999015978.USD","IE0032431581.USD","LU0080751232.USD","LU0043850808.USD","LU0320764599.SGD","LU0540923850.HKD","LU0501845795.SGD","LU0149721374.USD","LU0828238088.HKD","IE00B5MMRT66.SGD","LU1769817179.HKD","HK0000914660.USD","IE0009570106.USD","07630","LU1770034418.SGD","SG9999001903.USD","IE00B3M56506.USD","HK0000352291.HKD","SGXZ51526630.SGD","LU0823397103.USD","BK1516","LU0254981946.USD","SGXZ31699556.SGD","LU0327786744.USD","LU1226287875.USD","LU0048580855.USD","LU0589944569.HKD","LU2177674079.SGD","BK1526","LU0593848301.USD","LU0127658192.USD","IE0034224299.USD","LU0502904849.HKD","LU0431992006.USD","LU0314109678.HKD","SG9999014914.USD","LU1102505929.USD","LU1048484197.HKD","SGXZ81514606.USD","LU1226287792.SGD","LU0594300419.USD","LU1196710864.SGD","LU0738912210.USD","LU0577902298.EUR","LU1051769294.HKD","SG9999000418.SGD","SG9999000327.SGD","SG9999001051.SGD","LU0823413660.USD","LU0287142896.SGD","SG9999014674.SGD","LU0700851271.USD","LU0972618739.USD","LU0516422952.EUR","LU0871576103.HKD","LU1439103000.SGD","LU0651946864.USD","LU1993786604.SGD","SG9999014880.SGD","LU1046422090.SGD","LU0117841782.USD","LU0708995153.HKD","SG9999002463.SGD","LU0051755006.USD","LU0348783662.USD","LU0588545904.SGD","LU1719994722.HKD","IE00B031HW06.USD","LU2039709279.SGD","LU0823040885.USD","BK1608","IE00BQXX3D17.EUR","IE00BZ08YR35.GBP","LU0633140727.USD","LU1733274390.USD","LU0737861772.HKD","LU1734074674.USD","LU0192582467.USD","LU0164872284.USD","LU0289960550.SGD","BK1591","LU1808992512.USD","TCHmain","LU0979878070.USD","LU1316542783.SGD","LU2476274720.SGD","LU0128522157.USD","LU3063872942.SGD","LU0516423091.SGD","LU0011963245.USD","LU2097828714.EUR","BK1618","LU0210533765.USD","BK1589","SG9999006597.SGD","LU0106959298.USD","LU0228659784.USD","LU0348827113.USD","LU0203345920.USD","LU0488056044.USD","LU0072462343.USD","LU0819121731.USD","LU0054237671.USD","SG9999002562.SGD","SG9999015945.SGD","LU0169518387.USD","LU0572939691.SGD","BK4550","LU1323998911.USD","LU2237443549.SGD","SGXZ90724238.SGD","LU0499858602.USD","LU1868838027.USD","LU0449509016.USD","LU0868486357.SGD","IE00B97KM107.HKD","LU0061477393.USD","LU1769817096.USD","BK4585","LU0898667661.SGD","LU1282649810.SGD","IE00B0169N27.USD","LU1366334578.USD","LU0886674414.USD","LU1226288253.USD","LU0029875118.USD","LU1282651121.HKD","BK1531","LU0541501648.USD","LU0348723411.USD","LU2152927971.USD","LU0608807433.USD","LU1515016050.SGD","LU0819123356.HKD","LU1044875133.USD","LU2226246903.HKD","BK1609","LU0823041008.USD","LU2106854487.HKD","SG9999001689.USD","LU2237443382.USD","IE0008369823.USD","LU0572940350.SGD","LU1688375341.USD","SG9999017495.SGD","LU0231483743.USD","LU2237443465.HKD","BK1502","LU2237443895.HKD","LU0865486749.SGD","LU0784639295.USD","LU1642822792.SGD","LU1956131251.USD","LU0107464264.USD","LU0862451753.SGD","IE00BZ08YT58.USD","LU0348816934.USD","LU1568876251.USD","LU0823413587.USD","LU0594300179.USD","LU1048596156.SGD","LU0072913022.USD","LU0572944931.SGD","LU0873338254.USD","LU0359202008.SGD","LU1960683339.HKD","LU0210526637.USD","LU1196710195.USD","LU0516422366.SGD","LU0106252389.USD","LU0417516571.SGD","LU0140636845.USD","LU0828237940.HKD","LU2257852520.SGD","LU0052750758.USD","HK0000914686.HKD","LU0196878994.USD","BK1521","LU0328353924.USD","LU0831103253.SGD","LU1051768304.USD","SG9999001069.SGD","LU0469268626.HKD","SG9999001846.SGD","LU0070217475.USD","LU0828237510.HKD","LU1224444064.USD","LU0890818403.SGD","LU0329678170.USD","LU2362541513.USD","LU0261950983.USD","HK0000151867.HKD","IE00B031J352.USD","SGXZ99366536.SGD","LU0449515922.USD","LU1733274473.HKD","SG9999002828.SGD","HK0000320264.USD","LU1655091459.SGD","LU0588545490.SGD","LU0417516902.SGD","LU0048388663.USD","IE0032834883.USD","IE00BF5LJ272.USD","HK0000352382.USD","LU1226288170.HKD","LU2237443622.USD","LU0348805143.USD","LU0348784397.USD","IE00B543WZ88.USD","IE00B29SXG58.USD","LU0543330566.HKD","LU2317271919.USD","HK0000306685.HKD","HK0001040168.HKD","LU1211504680.USD","LU0345769128.USD","LU0315178854.USD","LU0320764755.SGD","LU1044874839.SGD","LU1064131003.USD","LU0648948544.HKD","LU1807302812.USD","LU0348825331.USD","SG9999003461.SGD","LU1102505762.USD","LU1282648689.USD","LU0577902454.USD","LU1328277881.USD","HK0001040143.USD","LU0650527681.SGD","LU2399975544.HKD","LU0531970944.HKD","LU0708995583.HKD","LU0856984785.SGD","LU2294711473.HKD","LU1718418525.SGD","IE00B067MR52.USD","SG9999018865.SGD","LU0348788117.USD","LU0269904917.USD","LU0642271901.SGD","LU0577902371.SGD","IE00B0JY6N72.USD","LU2476274308.USD","LU0561508036.HKD","LU1366334651.USD","LU0791590937.USD","LU1282649067.USD","LU0675040207.SGD","LU0918141705.HKD","LU1188198961.HKD","LU0214875030.USD","LU0455707207.USD","LU0048597586.USD","LU0672654166.SGD","BK1610","LU0345776255.USD","IE00BQXX3C00.GBP","LU0173614495.USD","LU0326948709.USD","LU1814569148.SGD","LU2462611646.USD","IE0008368411.USD","HTCD.SI","LU0791591158.USD","LU0878005551.USD","LU0651947912.USD","LU0786609619.USD","BK4077","LU0823426308.USD","SG9999004220.SGD","LU0128522744.USD","LU1691799644.USD","LU0096374516.USD","LU0163747925.USD","LU0441854154.USD","LU0345775950.USD","LU0132412106.USD","LU0049112450.USD","LU0348814723.USD","LU1868837722.USD","BK1095","SG9999000459.SGD","LU0181495838.USD","LU0348783233.USD","LU0049853897.USD","LU0880133367.SGD","LU2051468812.USD","LU2265009873.SGD","LU1481107354.HKD","SG9999015986.USD","BK1586","LU0164865239.USD","LU1282649141.HKD","LU2279701549.SGD","LU1981816686.USD","LU0359201885.HKD","HK0000306701.USD","LU0348735423.USD","SG9999001226.SGD","LU0608807946.USD","LU2449936058.SGD","LU2778985437.USD","LU0029874905.USD","IE00B8HQ1Z84.USD","LU0315179316.USD","SG9999018857.SGD","LU1804176565.USD","LU0251144936.SGD","BK4581","LU0039217434.USD","LU0329678337.USD","LU0259732245.USD","LU0823038988.USD","LU0307460666.USD","LU2251237306.USD","LU0499858438.USD","LU0588545730.USD","LU1629966141.USD","SG9999014898.SGD","LU0516422440.USD","LU0878004406.USD","LU1242518931.SGD","LU1048588211.SGD","SG9999013353.USD","LU0607220059.USD","LU0882747503.HKD","LU2125910500.SGD","LU0229945570.USD","LU0235996351.USD","IE00BQXX3F31.USD","LU1868837565.USD","LU0084288322.USD","LU1974910355.USD","SG9999015952.SGD","LU0384037296.USD","LU2362541273.HKD","LU1917777945.USD","LU2008162690.USD","LU2237443978.SGD","BK4588","LU0463099449.HKD","LU0326950275.SGD","BK1615","GB00BDT5M118.USD","LU0577902538.SGD","LU0143863198.USD","LU1226288097.SGD","LU1883866441.USD","SG9999001093.SGD","LU0541502299.USD","LU1064130708.USD","LU0228367735.SGD","LU2097828557.USD","LU2125910849.SGD","LU0414403682.SGD","LU1152091168.USD","LU0293314216.USD","LU0117844026.USD","LU1303224171.USD","LU0456827905.SGD","LU1725190679.HKD","LU0797268264.HKD","LU2362540622.SGD","LU0165289439.USD","LU1023057109.AUD","LU1785774172.SGD","LU2097828474.EUR","LU0203347892.USD","LU0370786039.SGD","LU0588546209.SGD","LU0531971595.HKD","LU1008478684.HKD","LU0211977185.USD","LU0188438112.USD","LU0417516738.SGD","IE00B8L5B284.USD","LU2251237488.HKD","LU1105468828.SGD","LU1810669033.SGD","LU1770036033.HKD","LU0054450605.USD","LU0823397285.USD","LU0261947096.USD","LU0175139822.USD","LU0149534421.HKD","LU0577902611.USD","IE0003795394.USD","LU0516423174.USD","LU2097828631.EUR","LU0067412154.USD","LU1196710351.USD","LU1831875114.USD","LU2247934214.USD","LU0047713382.USD","IE0003851619.USD","LU1961090484.USD","LU0211331839.USD","LU0543330483.HKD","IE0003895053.USD","LU0143863784.USD","LU1044876610.USD","LU1152091754.HKD","LU0823039010.USD","IE00B031HY20.USD","LU1235295612.USD","LU1226287529.USD","LU0396098781.USD","LU0862451837.USD","IE00BPRC5H50.USD","IE0031814852.USD","BK1517","HK0000320223.HKD","LU0821914370.USD","LU1794554557.SGD","LU0345769631.USD","LU2045819591.USD","LU0106259558.USD","LU2148510915.USD","IE00BZ08YS42.EUR","LU1880383366.USD","LU0359201612.USD","LU2023250504.SGD","LU1439102457.SGD","LU1504937902.USD","LU1282651048.USD","LU2133065610.SGD","LU1720050803.USD","LU1328615791.USD","LU0918141887.USD","LU1813983027.USD","LU0264606111.USD","LU0605514214.HKD","LU0823426480.USD","LU1251922891.USD","LU1675838814.USD","LU0683595622.HKD","LU0244354667.USD","LU0985320562.USD","SG9999007991.SGD","LU0633140560.USD","LU0737861699.HKD","LU1224709979.USD","LU0456842615.SGD","LU2293587155.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104364617","title":"老虎暗盘｜英派药业-B涨超52%，每手赚约2100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1104364617","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104364617?lang=zh_cn&edition=full","pubTime":"2026-05-12 16:18","pubTimestamp":1778573929,"startTime":"0","endTime":"0","summary":"5月12日，$英派药业-B$暗盘涨超52%，总市值超84亿港元，每股定价20.10港元，每手200股；将于5月13日（周三）正式在港交所挂牌交易。截至最后实际可行日期，英派药业已构建了1款商业化产品、4款临床阶段产品、7款临床前产品的管线矩阵，覆盖PARP1/2、PARP1、 ATR、WEE1、PKMYT1/WEE1等关键合成致死靶点的小分子抑制剂。公司是全球仅有的三家同时拥有商业化阶段PARP1/2抑制剂及临床阶段下一代PARP1选择性抑制剂的企业之一。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8b649ba7014e19fc207e00040e470eb9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634296603","title":"新股暗盘 | 英派药业-B(07630)暗盘盘初涨近120% 每手赚4792港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2634296603","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634296603?lang=zh_cn&edition=full","pubTime":"2026-05-12 16:16","pubTimestamp":1778573784,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英派药业-B(07630)将于5月13日(周三)在香港挂牌。截至发稿，暗盘交易显示报价44.06港元，较招股价20.1港元上涨119.2%，每手200股，不计手续费，每手赚4792港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8b649ba7014e19fc207e00040e470eb9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440663.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07630","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633436901","title":"新股消息 | 英派药业-B(07630)招股结束 孖展认购额近1267亿港元 超购逾1387倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2633436901","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633436901?lang=zh_cn&edition=full","pubTime":"2026-05-08 16:50","pubTimestamp":1778230227,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，英派药业-B于5月5日至5月8日招股。截至5月8日中午，英派药业招股已结束，共获得1266.95亿港元孖展认购，以公开发售集资额0.913亿港元计，超购1387.64倍。根据招股计划，公司拟全球发售4197.7万股H股，其中香港公开发售占约10%。发售价每股19.75-21.75港元，每手200股H股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439549.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633918418","title":"新股孖展统计 | 5月6日","url":"https://stock-news.laohu8.com/highlight/detail?id=2633918418","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633918418?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:27","pubTimestamp":1778063248,"startTime":"0","endTime":"0","summary":"英派药业-B(07630)、剂泰科技-P(07666)正在招股中。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260506/20260506182748_22433.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260506/20260506182748_22433.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["07630","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114924651","title":"“港股合成致死肿瘤药第一股”英派药业启动招股，明星基石加持，拟5月13日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1114924651","media":"同壁财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114924651?lang=zh_cn&edition=full","pubTime":"2026-05-06 15:27","pubTimestamp":1778052443,"startTime":"0","endTime":"0","summary":"据消息，南京英派药业股份有限公司于2026年5月5日至8日开启招股， 公司拟全球发售约4198万股H股，每股发售价最高至21.75港元，募资规模最高超9亿港元。公司预计将于2026年5月13日在港股主板上市。其中，IMP32是全球首个、且目前唯一靶向CEACAM5的TOP1i+ATRi双载荷ADC，凭借明确的合成致死协同效应，已成为全球巨头战略布局的核心方向。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tongbicapital.com/news?id=1116351&feClassCode=hsag","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1668077363049","symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123297572","title":"即将亮相：港股合成致死肿瘤药第一股英派药业","url":"https://stock-news.laohu8.com/highlight/detail?id=1123297572","media":"医药投资部落","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123297572?lang=zh_cn&edition=full","pubTime":"2026-05-06 15:25","pubTimestamp":1778052358,"startTime":"0","endTime":"0","summary":"汇聚了中国创新药行业核心资产的港股18A板块，即将迎来又一家创新药细分赛道的龙头企业：有着“合成致死肿瘤药第一股”之称的英派药业，已在5月5日开启港股招股流程，预计5月13日于香港联交所主板挂牌上市。新技术赛道扩展市场往往习惯将英派药业定位为一家深度绑定合成致死赛道的小分子药物公司，这一判断并不全面。这意味着，英派药业的技术半径正从合成致死小分子药物赛道，延伸到围绕肿瘤治疗的多种前沿技术路线。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://mp.weixin.qq.com/s/IRYuOSKv3y13KkTaFyQC4A?from=groupmessage&scene=1&subscene=10000&sessionid=1778048506&clicktime=1778050535&enterid=1778050535&ascene=1&fasttmpl_type=0&fasttmpl_fullversion=8237539-zh_CN-zip&fasttmpl_flag=0&realreporttime=1778050535337","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1629166856219","symbols":["07630"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633092917","title":"港股18A再迎明星biotech，英派药业招股开始，合成致死稀缺标的获豪华基石认购","url":"https://stock-news.laohu8.com/highlight/detail?id=2633092917","media":"信阳新闻网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633092917?lang=zh_cn&edition=full","pubTime":"2026-05-05 19:43","pubTimestamp":1777981409,"startTime":"0","endTime":"0","summary":"2026年5月5日，南京英派药业股份有限公司（简称“英派药业”，股票代码:07630.HK）开启招股，拟全球发售约4198万股H股(视乎发售量调整权及超额配股权行使与否而定)，其中中国香港发售股份约420万股，国际发售股份约3778万股；2026年5月5日至5月8日招股，每股发售价格最高至21.75港元，每手买卖单位为200股，募集资金规模最高超9亿港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.p5w.net/roll/finance/202605/t20260505_6469559.htm","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1778052843920","symbols":["07630","BK4087","BK4588","VXUS","IPOS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.impacttherapeutics.com","stockEarnings":[{"period":"1week","weight":0.8985},{"period":"ytd","weight":0.8985}],"compareEarnings":[{"period":"1week","weight":-0.0277},{"period":"1month","weight":-0.0185},{"period":"3month","weight":-0.0386},{"period":"6month","weight":-0.006},{"period":"1year","weight":0.0998},{"period":"ytd","weight":0.0017}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"南京英派药业股份有限公司是一家主要从事生物技术研发和商业化的中国公司。该公司处于商业化阶段。该公司致力于在全球范围内推进基于合成致死（SL）机制的精准抗癌疗法。该公司自主研发的核心产品塞纳帕利已在中国获批上市，作为卵巢癌（OC）一线维持疗法。该公司正在研发的产品管线包PARP1/2、PARP1、ATR、WEE1、PKMYT1/WEE1、DHX9、ATM、USP1及CHK1/2等。","exchange":"SEHK","name":"英派药业-B","nameEN":"IMPACT THERAP-B"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"英派药业-B(07630)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供英派药业-B(07630)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"英派药业-B,07630,英派药业-B股票,英派药业-B股票老虎,英派药业-B股票老虎国际,英派药业-B行情,英派药业-B股票行情,英派药业-B股价,英派药业-B股市,英派药业-B股票价格,英派药业-B股票交易,英派药业-B股票购买,英派药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"英派药业-B(07630)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供英派药业-B(07630)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}